Chicago home rental company Kairos Living continues its expansion within the South Haven development in Denham Springs with ...

Kairos Pharma (NYSE American: KAPA) , a clinical-stage biopharma company advancing cancer therapeutics, will participate in the H.C. Wainwright 27th ...

Carotuximab plus Erleada proved safe in the first 10 patients with metastatic castration-resistant prostate cancer dosed on ...

Affiliates of Harbor Group International LLC (HGI) have provided a $38.3 million loan for the refinancing of a 12-story office building located at 1250 Eye St. in Washington, D.C.’s East End district.

LOS ANGELES, CA, USA I July 15 2025 I Kairos Pharma, Ltd. (NYSE American:KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer ...

Kairos Pharma, Ltd. (NYSE American:KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces participation and presentation at the H.C. Wainwright ...

The long-gestating rules outlining what can be built where in the core of downtown Boston will get at least another few weeks ...

A landmark event in the Philippine energy sector took place as the Institute for Climate and Sustainable Cities (ICSC) ...

Kairos Investment Management Co. purchased the 1980s-era building at the end of 2023 for athird of its prior sale price.

Kairos Investment Management landed a $38.3 million senior loan from Harbor Group International (HGI) for 1250 I Street NW, a ...

Kairos Pharma shares were higher as the company reported positive safety results from a clinical trial of ENV-105, or carotuximab, in patients with metastatic castration-resistant prostate cancer.

Kairos Pharma Ltd (NYSE:KAPA) saw its stock jump 165% following the announcement of encouraging safety results from its ongoing Phase 2 clinical trial of ENV-105 in patients battling metastatic ...